Sievi, Noriane A.
Schmidt, Felix
Baur, Diego M.
Fricke, Kai
Herth, Jonas
Serényi, Dora
Roeder, Maurice
Mosca, Nicole
Vesenbeckh, Silvan
Ulrich, Silvia
Clarenbach, Christian F.
Kohler, Malcolm
Funding for this research was provided by:
AstraZeneca Schweiz
Article History
Received: 5 December 2025
Accepted: 25 February 2026
First Online: 3 March 2026
Declarations
:
: The study was approved by the cantonal ethics committee of Zurich (BASEC-Nr. 2021–00539) and adhered to the principles of the Declaration of Helsinki and Good Clinical Practice. The study was registered at ClinicalTrials.gov (NCT05458934) and all participants provided written informed consent.
: The authors declare no competing interests.